BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giraud AS, Menheniott TR, Judd LM. Targeting STAT3 in gastric cancer. Expert Opin Ther Targets. 2012;16:889-901. [PMID: 22834702 DOI: 10.1517/14728222.2012.709238] [Cited by in Crossref: 61] [Cited by in F6Publishing: 68] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Dong J, Yang J, Yu W, Li H, Cai M, Xu JL, Xu HD, Shi YF, Guan X, Cheng XD, Qin JJ. Discovery of benzochalcone derivative as a potential antigastric cancer agent targeting signal transducer and activator of transcription 3 (STAT3). J Enzyme Inhib Med Chem 2022;37:2004-16. [PMID: 35844184 DOI: 10.1080/14756366.2022.2100366] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ni Y, Low JT, Silke J, O'Reilly LA. Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers. Front Immunol 2022;13:835997. [PMID: 35844493 DOI: 10.3389/fimmu.2022.835997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhong Y, Deng L, Shi S, Huang QY, Ou-Yang SM, Mo JS, Zhu K, Qu XM, Liu PQ, Wang YX, Zhang XL. The novel STAT3 inhibitor WZ-2-033 causes regression of human triple-negative breast cancer and gastric cancer xenografts. Acta Pharmacol Sin 2022;43:1013-23. [PMID: 34267347 DOI: 10.1038/s41401-021-00718-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Danesh Pouya F, Rasmi Y, Nemati M. Signaling Pathways Involved in 5-FU Drug Resistance in Cancer. Cancer Invest 2022;:1-28. [PMID: 35320055 DOI: 10.1080/07357907.2022.2055050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Rah B, Rather RA, Bhat GR, Baba AB, Mushtaq I, Farooq M, Yousuf T, Dar SB, Parveen S, Hassan R, Mohammad F, Qassim I, Bhat A, Ali S, Zargar MH, Afroze D. JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies. Front Pharmacol 2022;13:821344. [DOI: 10.3389/fphar.2022.821344] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
6 Lee H, Lee I, Kang K, Park S, Jung M, Yang SG, Kwon T, Lee D. A Network Pharmacology Perspective Investigation of the Pharmacological Mechanisms of the Herbal Drug FDY003 in Gastric Cancer. Natural Product Communications 2022;17:1934578X2110730. [DOI: 10.1177/1934578x211073030] [Reference Citation Analysis]
7 Kim SJ, Kang HG, Kim K, Kim H, Zetterberg F, Park YS, Cho HS, Hewitt SM, Chung JY, Nilsson UJ, Leffler H, Chun KH. Crosstalk between WNT and STAT3 is mediated by galectin-3 in tumor progression. Gastric Cancer 2021;24:1050-62. [PMID: 33834359 DOI: 10.1007/s10120-021-01186-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Park JM, An JM, Han YM, Surh YJ, Hwang SJ, Kim SJ, Hahm KB. Walnut polyphenol extracts inhibit <i>Helicobacter pylori</i>-induced STAT3<sup>Tyr705</sup> phosphorylation through activation of PPAR-γ and SOCS1 induction. J Clin Biochem Nutr . [DOI: 10.3164/jcbn.20-105] [Reference Citation Analysis]
9 Park JM, Han YM, Park YJ, Hahm KB. Dietary intake of walnut prevented Helicobacter pylori-associated gastric cancer through rejuvenation of chronic atrophic gastritis. J Clin Biochem Nutr 2021;68:37-50. [PMID: 33536711 DOI: 10.3164/jcbn.20-103] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Park JM, An JM, Han YM, Surh YJ, Hwang SJ, Kim SJ, Hahm KB. Walnut polyphenol extracts inhibit Helicobacter pylori-induced STAT3Tyr705 phosphorylation through activation of PPAR-γ and SOCS1 induction. J Clin Biochem Nutr 2020;67:248-56. [PMID: 33293765 DOI: 10.3164/jcbn.20-89] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
11 Zhang Y, Ma S, Niu Q, Han Y, Liu X, Jiang J, Chen S, Lin H. Features of alternative splicing in stomach adenocarcinoma and their clinical implication: a research based on massive sequencing data. BMC Genomics 2020;21:580. [PMID: 32831016 DOI: 10.1186/s12864-020-06997-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
12 Li D, Zhao L, Li Y, Kang X, Zhang S. Gastro-Protective Effects of Calycosin Against Precancerous Lesions of Gastric Carcinoma in Rats. Drug Des Devel Ther 2020;14:2207-19. [PMID: 32606591 DOI: 10.2147/DDDT.S247958] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zhang X, Lu T, Ma Y, Li R, Pang Y, Mao H, Liu P. Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo. Onco Targets Ther 2020;13:5069-82. [PMID: 32606729 DOI: 10.2147/OTT.S247398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Xu J, Chen Y, Yang R, Zhou T, Ke W, Si Y, Yang S, Zhang T, Liu X, Zhang L, Xiang K, Guo Y, Liu Y. Cucurbitacin B inhibits gastric cancer progression by suppressing STAT3 activity. Arch Biochem Biophys 2020;684:108314. [PMID: 32088220 DOI: 10.1016/j.abb.2020.108314] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
15 Chen J, Liu H, Chen J, Sun B, Wu J, Du C. PLXNC1 Enhances Carcinogenesis Through Transcriptional Activation of IL6ST in Gastric Cancer. Front Oncol 2020;10:33. [PMID: 32117710 DOI: 10.3389/fonc.2020.00033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
16 Li X, Na H, Xu L, Zhang X, Feng Z, Zhou X, Cui J, Zhang J, Lin F, Yang S, Yue F, Mousa H, Zuo Y. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression. Biomed Pharmacother 2020;121:109644. [PMID: 31766099 DOI: 10.1016/j.biopha.2019.109644] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
17 Wei KL, Chou JL, Chen YC, Jin H, Chuang YM, Wu CS, Chan MWY. Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer. PLoS One 2019;14:e0218338. [PMID: 31194837 DOI: 10.1371/journal.pone.0218338] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
18 Hwang ST, Kim C, Lee JH, Chinnathambi A, Alharbi SA, Shair OHM, Sethi G, Ahn KS. Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells. Phytomedicine 2019;59:152907. [PMID: 30981183 DOI: 10.1016/j.phymed.2019.152907] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 10.0] [Reference Citation Analysis]
19 Koh JS, Joo MK, Park JJ, Yoo HS, Choi BI, Lee BJ, Chun HJ, Lee SW. Inhibition of STAT3 in gastric cancer: role of pantoprazole as SHP-1 inducer. Cell Biosci. 2018;8:50. [PMID: 30202514 DOI: 10.1186/s13578-018-0248-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
20 Liu MJ, Jiang K, Zhang J, Zhou L, Zhao JW, Wang BM. RIP3 mediates IL-33 production in gastric epithelial cells with intestinal metaplasia. Shijie Huaren Xiaohua Zazhi 2018; 26(16): 964-971 [DOI: 10.11569/wcjd.v26.i16.964] [Reference Citation Analysis]
21 Pandey A, Tripathi SC, Shukla S, Mahata S, Vishnoi K, Misra SP, Misra V, Mitra S, Dwivedi M, Bharti AC. Differentially localized survivin and STAT3 as markers of gastric cancer progression: Association with Helicobacter pylori. Cancer Rep (Hoboken) 2018;1:e1004. [PMID: 32729225 DOI: 10.1002/cnr2.1004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
22 Kim SH, Yoo HS, Joo MK, Kim T, Park JJ, Lee BJ, Chun HJ, Lee SW, Bak YT. Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells. BMC Cancer 2018;18:150. [PMID: 29409467 DOI: 10.1186/s12885-018-4071-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
23 Nie GQ, Wang XQ, Yang MY. E804, a derivative of indirubin, promotes autophagy of gastric cancer cells through Stat3 signaling pathway. Shijie Huaren Xiaohua Zazhi 2017; 25(36): 3184-3190 [DOI: 10.11569/wcjd.v25.i36.3184] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Khanna P, Chua PJ, Wong BSE, Yin C, Thike AA, Wan WK, Tan PH, Baeg GH. GRAM domain-containing protein 1B (GRAMD1B), a novel component of the JAK/STAT signaling pathway, functions in gastric carcinogenesis. Oncotarget 2017;8:115370-83. [PMID: 29383166 DOI: 10.18632/oncotarget.23265] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
25 Cao Y, Liu H, Zhang H, Lin C, Li R, Wu S, Li H, He H, Zhang W, Xu J. CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients. Oncotarget 2017;8:20328-39. [PMID: 27780937 DOI: 10.18632/oncotarget.12815] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
26 Saito M, Okayama H, Saito K, Ando J, Kumamoto K, Nakamura I, Ohki S, Ishi Y, Takenoshita S. CDX2 is involved in microRNA-associated inflammatory carcinogenesis in gastric cancer. Oncol Lett 2017;14:6184-90. [PMID: 29113265 DOI: 10.3892/ol.2017.6956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
27 Deng ZH, Meng J, Tang J, Hu GY, Tao LJ. Fluorofenidone Inhibits the Proliferation of Lung Adenocarcinoma Cells. J Cancer 2017;8:1917-26. [PMID: 28819390 DOI: 10.7150/jca.18040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
28 Wang J, Zhang G, Dai C, Gao X, Wu J, Shen L, Chen Z, Liu P. Cryptotanshinone potentiates the antitumor effects of doxorubicin on gastric cancer cells via inhibition of STAT3 activity. J Int Med Res. 2017;45:220-230. [PMID: 28222632 DOI: 10.1177/0300060516685513] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
29 Jella KK. Activation of STAT3 in Gastric Cancer Development. Role of Transcription Factors in Gastrointestinal Malignancies 2017. [DOI: 10.1007/978-981-10-6728-0_11] [Reference Citation Analysis]
30 Syu LJ, Zhao X, Zhang Y, Grachtchouk M, Demitrack E, Ermilov A, Wilbert DM, Zheng X, Kaatz A, Greenson JK. Invasive mouse gastric adenocarcinomas arising from Lgr5+ stem cells are dependent on crosstalk between the Hedgehog/GLI2 and mTOR pathways. Oncotarget. 2016;7:10255-10270. [PMID: 26859571 DOI: 10.18632/oncotarget.7182] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
31 Gan J, Ke X, Jiang J, Dong H, Yao Z, Lin Y, Lin W, Wu X, Yan S, Zhuang Y, Chu WK, Cai R, Zhang X, Cheung HS, Block NL, Pang CP, Schally AV, Zhang H. Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1-STAT3/NF-κB signaling. Proc Natl Acad Sci U S A 2016;113:14745-50. [PMID: 27930339 DOI: 10.1073/pnas.1618582114] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 7.3] [Reference Citation Analysis]
32 Cao Y, Zhang H, Liu H, Lin C, Li R, Wu S, He H, Li H, Xu J. Glycoprotein 130 is associated with adverse postoperative clinical outcomes of patients with late-stage non-metastatic gastric cancer. Sci Rep 2016;6:38364. [PMID: 27917904 DOI: 10.1038/srep38364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
33 Pratheeshkumar P, Son YO, Divya SP, Wang L, Zhang Z, Shi X. Oncogenic transformation of human lung bronchial epithelial cells induced by arsenic involves ROS-dependent activation of STAT3-miR-21-PDCD4 mechanism. Sci Rep 2016;6:37227. [PMID: 27876813 DOI: 10.1038/srep37227] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
34 Piao JY, Lee HG, Kim SJ, Kim DH, Han HJ, Ngo HK, Park SA, Woo JH, Lee JS, Na HK, Cha YN, Surh YJ. Helicobacter pylori Activates IL-6-STAT3 Signaling in Human Gastric Cancer Cells: Potential Roles for Reactive Oxygen Species. Helicobacter 2016;21:405-16. [PMID: 26910614 DOI: 10.1111/hel.12298] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
35 Yum HW, Na HK, Surh YJ. Anti-inflammatory effects of docosahexaenoic acid: Implications for its cancer chemopreventive potential. Semin Cancer Biol 2016;40-41:141-59. [PMID: 27546289 DOI: 10.1016/j.semcancer.2016.08.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
36 Yu B, Lv X, Su L, Li J, Yu Y, Gu Q, Yan M, Zhu Z, Liu B. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer. PLoS One 2016;11:e0158961. [PMID: 27518872 DOI: 10.1371/journal.pone.0158961] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
37 Joo MK, Park JJ, Chun HJ. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management. World J Gastroenterol 2016; 22(19): 4638-4650 [PMID: 27217696 DOI: 10.3748/wjg.v22.i19.4638] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
38 Ji HG, Piao JY, Kim SJ, Kim DH, Lee HN, Na HK, Surh YJ. Docosahexaenoic acid inhibits Helicobacter pylori-induced STAT3 phosphorylation through activation of PPARγ. Mol Nutr Food Res 2016;60:1448-57. [PMID: 27079734 DOI: 10.1002/mnfr.201600009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
39 Zhu L, Cheng X, Shi J, Jiacheng L, Chen G, Jin H, Liu AB, Pyo H, Ye J, Zhu Y. Crosstalk between bone marrow-derived myofibroblasts and gastric cancer cells regulates cancer stemness and promotes tumorigenesis. Oncogene. 2016;35:5388-5399. [PMID: 27109105 DOI: 10.1038/onc.2016.76] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
40 Wang XY, Wang LL, Zheng X, Meng LN, Lyu B, Jin HF. Expression of p-STAT3 and vascular endothelial growth factor in MNNG-induced precancerous lesions and gastric tumors in rats. World J Gastrointest Oncol 2016; 8(3): 305-313 [PMID: 26989466 DOI: 10.4251/wjgo.v8.i3.305] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
41 Zhang X, Tang J, Zhi X, Xie K, Wang W, Li Z, Zhu Y, Yang L, Xu H, Xu Z. miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer. Oncotarget 2015;6:1605-17. [PMID: 25596740 DOI: 10.18632/oncotarget.2748] [Cited by in Crossref: 72] [Cited by in F6Publishing: 81] [Article Influence: 9.0] [Reference Citation Analysis]
42 Wang X, Zhang Y, Jiang L, Zhou F, Zhai H, Zhang M, Wang J. Interpreting the distinct and shared genetic characteristics between Epstein-Barr virus associated and non-associated gastric carcinoma. Gene. 2016;576:798-806. [PMID: 26584536 DOI: 10.1016/j.gene.2015.11.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
43 Joo MK, Park JJ, Yoo HS, Lee BJ, Chun HJ, Lee SW, Bak YT. Epigenetic regulation and anti-tumorigenic effects of SH2-containing protein tyrosine phosphatase 1 (SHP1) in human gastric cancer cells. Tumour Biol. 2016;37:4603-4612. [PMID: 26508024 DOI: 10.1007/s13277-015-4228-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
44 Menheniott TR, Judd LM, Giraud AS. STAT3: a critical component in the response to Helicobacter pylori infection. Cell Microbiol 2015;17:1570-82. [PMID: 26332850 DOI: 10.1111/cmi.12518] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
45 You LL, Cao DH, Jiang J, Hou Z, Suo YE, Wang SD, Cao XY. Transgenic mouse models of gastric cancer: Pathological characteristic and applications. Shijie Huaren Xiaohua Zazhi 2015; 23(17): 2754-2760 [DOI: 10.11569/wcjd.v23.i17.2754] [Reference Citation Analysis]
46 Ma Y, Zhang X, Xu X, Shen L, Yao Y, Yang Z, Liu P. STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells. PLoS One 2015;10:e0124924. [PMID: 25923701 DOI: 10.1371/journal.pone.0124924] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
47 Qi P, Xu MD, Shen XH, Ni SJ, Huang D, Tan C, Weng WW, Sheng WQ, Zhou XY, Du X. Reciprocal repression between TUSC7 and miR-23b in gastric cancer. Int J Cancer. 2015;137:1269-1278. [PMID: 25765901 DOI: 10.1002/ijc.29516] [Cited by in Crossref: 63] [Cited by in F6Publishing: 69] [Article Influence: 7.9] [Reference Citation Analysis]
48 Ryan RE, Martin B, Mellor L, Jacob RB, Tawara K, McDougal OM, Oxford JT, Jorcyk CL. Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasis. Cytokine 2015;72:71-85. [PMID: 25622278 DOI: 10.1016/j.cyto.2014.11.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
49 Neurath MF, Fichtner-feigl S, Kesselring R. Intestinal Inflammation and Cancer of the Gastrointestinal Tract. Mucosal Immunology 2015. [DOI: 10.1016/b978-0-12-415847-4.00091-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Ou H, Li Y, Kang M. Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene. PLoS One 2014;9:e109929. [PMID: 25365510 DOI: 10.1371/journal.pone.0109929] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
51 Aoyagi K, Kouhuji K, Kizaki J, Isobe T, Hashimoto K, Shirouzu K. Molecular targeting to treat gastric cancer. World J Gastroenterol 2014; 20(38): 13741-13755 [PMID: 25320512 DOI: 10.3748/wjg.v20.i38.13741] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
52 Zhu H, Chen X, Chen B, Chen B, Fan J, Song W, Xie Z, Jiang D, Li Q, Zhou M. Activating transcription factor 4 mediates a multidrug resistance phenotype of esophageal squamous cell carcinoma cells through transactivation of STAT3 expression. Cancer Lett. 2014;354:142-152. [PMID: 25130172 DOI: 10.1016/j.canlet.2014.07.044] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
53 Katsha A, Arras J, Soutto M, Belkhiri A, El-Rifai W. AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers. Mol Oncol. 2014;8:1419-1428. [PMID: 24953013 DOI: 10.1016/j.molonc.2014.05.012] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
54 Park JM, Park SH, Hong KS, Han YM, Jang SH, Kim EH, Hahm KB. Special licorice extracts containing lowered glycyrrhizin and enhanced licochalcone A prevented Helicobacter pylori-initiated, salt diet-promoted gastric tumorigenesis. Helicobacter 2014;19:221-36. [PMID: 24646026 DOI: 10.1111/hel.12121] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
55 Yuan K, Liu H, Huang L, Ren X, Liu J, Dong X, Tian W, Jia Y. rs744166 polymorphism of the STAT3 gene is associated with risk of gastric cancer in a Chinese population. Biomed Res Int 2014;2014:527918. [PMID: 24864251 DOI: 10.1155/2014/527918] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
56 Yao J, Qian CJ, Ye B, Zhao ZQ, Wei J, Liang Y, Zhang X. Signal transducer and activator of transcription 3 signaling upregulates fascin via nuclear factor-κB in gastric cancer: Implications in cell invasion and migration. Oncol Lett 2014;7:902-8. [PMID: 24527098 DOI: 10.3892/ol.2014.1804] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
57 Senol K, Ozkan MB, Vural S, Tez M. The role of inflammation in gastric cancer. Adv Exp Med Biol 2014;816:235-57. [PMID: 24818726 DOI: 10.1007/978-3-0348-0837-8_10] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
58 Zhang L, Xu Z, Xu X, Zhang B, Wu H, Wang M, Zhang X, Yang T, Cai J, Yan Y, Mao F, Zhu W, Shao Q, Qian H, Xu W. SALL4, a novel marker for human gastric carcinogenesis and metastasis. Oncogene 2014;33:5491-500. [PMID: 24276240 DOI: 10.1038/onc.2013.495] [Cited by in Crossref: 77] [Cited by in F6Publishing: 89] [Article Influence: 7.7] [Reference Citation Analysis]
59 Wang Z, Si X, Xu A, Meng X, Gao S, Qi Y, Zhu L, Li T, Li W, Dong L. Activation of STAT3 in human gastric cancer cells via interleukin (IL)-6-type cytokine signaling correlates with clinical implications. PLoS One. 2013;8:e75788. [PMID: 24116074 DOI: 10.1371/journal.pone.0075788] [Cited by in Crossref: 43] [Cited by in F6Publishing: 51] [Article Influence: 4.3] [Reference Citation Analysis]
60 Lu SM, Chen MR, Xuan JY, Liu LN, Lv S, Li Y. Relationship between STAT3 activation and epithelial-mesenchymal transition in gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2013; 21(26): 2748-2753 [DOI: 10.11569/wcjd.v21.i26.2748] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Inagaki-Ohara K, Kondo T, Ito M, Yoshimura A. SOCS, inflammation, and cancer. JAKSTAT. 2013;2:e24053. [PMID: 24069550 DOI: 10.4161/jkst.24053] [Cited by in Crossref: 76] [Cited by in F6Publishing: 118] [Article Influence: 7.6] [Reference Citation Analysis]